Ella Evron

Jerusalem, JM, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Correction: Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer.

Correction: Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer.

Journal: Oncogene

Published: September 05, 2025

Prophylactic Irradiation of the Contralateral Breast for BRCA Carriers With Early Breast Cancer: A Nonrandomized Clinical Trial.

Prophylactic Irradiation of the Contralateral Breast for BRCA Carriers With Early Breast Cancer: A Nonrandomized Clinical Trial.

Journal: JAMA oncology

Published: May 08, 2025

ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes.

ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes.

Journal: Breast cancer research and treatment

Published: June 11, 2024

Leveraging Comprehensive Health Records for Breast Cancer Risk Prediction: A Binational Assessment.

Leveraging Comprehensive Health Records for Breast Cancer Risk Prediction: A Binational Assessment.

Journal: AMIA ... Annual Symposium proceedings. AMIA Symposium

Published: May 02, 2023

Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes-exploratory analysis of the Clalit registry.

Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes-exploratory analysis of the Clalit registry.

Journal: NPJ breast cancer

Published: March 18, 2023

Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study.

Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study.

Journal: NPJ breast cancer

Published: November 23, 2022

Nonsurgical Options for Risk Reduction of Contralateral Breast Cancer in BRCA Mutation Carriers With Early-Stage Breast Cancer.

Nonsurgical Options for Risk Reduction of Contralateral Breast Cancer in BRCA Mutation Carriers With Early-Stage Breast Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 28, 2022

Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2.

Controversies and Open Questions in Management of Cancer-Free Carriers of Germline Pathogenic Variants in BRCA1/BRCA2.

Journal: Cancers

Published: July 27, 2022

Genetic testing in patients with triple-negative or hereditary breast cancer.

Genetic testing in patients with triple-negative or hereditary breast cancer.

Journal: Current opinion in oncology

Published: September 02, 2021

Risk-Reducing Mastectomy and Reconstruction Following Prophylactic Breast Irradiation: Hope Sustained.

Risk-Reducing Mastectomy and Reconstruction Following Prophylactic Breast Irradiation: Hope Sustained.

Journal: Cancers

Published: March 22, 2021

Breast-Specific Epigenetic Regulation of DeltaNp73 and Its Role in DNA-Damage-Response of BRCA1-Mutated Human Mammary Epithelial Cells.

Breast-Specific Epigenetic Regulation of DeltaNp73 and Its Role in DNA-Damage-Response of BRCA1-Mutated Human Mammary Epithelial Cells.

Journal: Cancers

Published: July 29, 2020

Radiation-Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast Cancer.

Radiation-Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast Cancer.

Journal: International journal of radiation oncology, biology, physics

Published: November 21, 2019

Showing 1-12 of 36

Last Updated: 09/26/2026